Opportunity Title : Pfizer-Astellas Alliance Grant for Urothelial Cancer 2026

The Pfizer-Astellas Alliance has launched this independent medical education grant opportunity to support educational activities addressing the rapidly evolving treatment landscape for urothelial cancer, including advanced and muscle-invasive bladder cancer.

Urothelial cancer management continues to evolve as new clinical evidence, treatment approaches, therapeutic combinations, and clinical guidelines emerge. These developments can create knowledge and practice gaps among healthcare professionals who are responsible for diagnosing, treating, and managing patients.

The programme therefore aims to support independent medical education that helps healthcare professionals remain informed about emerging evidence and apply appropriate clinical strategies in practice.

The initiative is intended for educational activities conducted outside the United States and is focused on improving the knowledge, competence, and clinical decision-making abilities of healthcare professionals.

Key educational objectives may include:

• Improving healthcare professionals’ understanding of current urothelial cancer treatment approaches.
• Addressing knowledge gaps surrounding muscle-invasive bladder cancer.
• Increasing awareness of emerging evidence and treatment strategies for advanced urothelial cancer.
• Supporting the application of current clinical evidence and best practices.
• Improving healthcare professionals’ ability to make informed treatment decisions.
• Encouraging multidisciplinary approaches to urothelial cancer management.
• Supporting continuing professional development and independent medical education.
• Ultimately contributing to improved quality of care for patients with urothelial cancer.

The programme is intended to fund independent educational activities, meaning the educational content and programme should be developed and delivered independently rather than being used as promotional activities.

Eligible applicants can request funding within the following range:

Minimum grant request: US$10,000
Maximum grant request: US$150,000

However, applicants should note that requesting a particular amount does not guarantee that the full amount will be awarded. The final grant amount may vary depending on the assessment of the proposed educational activity, its scope, educational needs, and available funding.

The grant is available to eligible organizations, rather than individual applicants.

Organizations that may be eligible include:

Medical, Nursing, Allied Health and Pharmacy Schools

Educational institutions that train healthcare professionals may apply where they have a relevant role in developing and delivering medical education related to urothelial cancer.

Healthcare Institutions

Both large and small healthcare institutions may be eligible, including organizations involved in healthcare delivery, professional development, and clinical education.

Professional Organizations and Medical Societies

Professional associations and medical societies whose missions include healthcare professional education, clinical improvement, or related activities may be eligible to submit applications.

Medical Education Companies

Organizations specializing in medical education may also apply, provided that they meet the programme's eligibility requirements and have an appropriate role in developing and implementing the educational activity.

Other Healthcare-Related Organizations

Other organizations may be considered where their mission is directly related to healthcare professional education and/or healthcare improvement.

6. Important Eligibility Conditions

Only organizations are eligible to receive the grant. Individuals are not eligible to receive funding directly.

Independent medical practice groups consisting solely of physicians who are not affiliated with a hospital, academic institution, professional society, or another eligible organization are also not eligible.

Where a proposed project involves multiple departments, institutions, organizations, or associations, each participating entity must have a relevant role in the project.

The organization submitting the application must have a key role in the proposed programme.

Project or Programme Lead

The applicant must be the project/programme lead or an authorized representative of the project/programme lead, such as a grant coordinator.

The project/programme lead must be:

• An employee of the requesting organization; or
• A contractor of the requesting organization.

This requirement helps ensure that the organization submitting the application has appropriate responsibility and oversight for the proposed educational activity.

7. Ability to Receive Grant Funding

The requesting organization must be legally capable of receiving grant funding directly from Astellas Pharma Global Development.

Applicants are strongly encouraged to confirm their organization's ability to receive the funds before submitting an application.

This is particularly important because an organization may meet the programme's educational eligibility requirements but still be unable to receive funding directly because of its legal, institutional, or financial structure.

If a grant is awarded to an organization that is later determined to be unable to receive funding directly, the grant may be rescinded. In circumstances where funding has already been provided, the organization may be required to return the funds.

8. Accreditation Requirement for Continuing Education

Organizations proposing activities that offer continuing education credit must be appropriately accredited by a reputable accreditation body.

Applicants should therefore verify that their organization has the necessary accreditation before submitting a proposal involving continuing education credits.

If accreditation is required for the proposed activity, applicants should ensure that all relevant accreditation standards are satisfied.

9. What Types of Projects May Be Considered?

The opportunity is intended to support educational initiatives that address important knowledge or practice gaps related to urothelial cancer.

Potential activities could include educational programmes focused on topics such as:

• Emerging treatment strategies for advanced urothelial cancer.
• Management of muscle-invasive bladder cancer.
• Interpretation and application of new clinical evidence.
• Multidisciplinary approaches to bladder cancer treatment.
• Clinical decision-making in changing treatment environments.
• Updates in standards of care and evidence-based treatment.
• Patient management considerations in advanced disease.
• Improving healthcare professionals' understanding of new therapeutic approaches.

Applicants should ensure that their proposed activity has a clearly defined educational need and demonstrates how the programme will improve healthcare professionals' knowledge, competence, or clinical practice.

Interested applicants should click the official application link for the Pfizer-Astellas Alliance Grant for Independent Medical Education on Urothelial Cancer 2026, review the complete guidelines, confirm eligibility, and submit their application through the designated application platform.

Important: Applicants should rely on the official grant guidelines and application portal for the latest information concerning deadlines, eligible activities, funding conditions, and submission requirements.